Stellar Capital Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
Stellar Capital Management's DGX Position: Q2 2020 in Review
Stellar Capital Management increased its Quest Diagnostics (DGX) stake by 6.2% in Q2 2020, buying an estimated $200K and bringing the position to 32,535 shares worth $3.71M. The position accounts for 2.52% of the portfolio, ranked #13.
Stellar Capital Management first reported a position in DGX in Q1 2014 and has held it in 25 quarters since. 748 funds tracked by Wall St. Rank hold DGX as of Q2 2020.
- Stellar Capital Management held 32,535 shares of Quest Diagnostics worth $3.71M as of Q2 2020.
- Stellar Capital Management bought 1,886 Quest Diagnostics shares in Q2 2020, an estimated $200K.
- Quest Diagnostics made up 2.52% of Stellar Capital Management's portfolio in Q2 2020, its #13 holding.
- Stellar Capital Management first reported a position in Quest Diagnostics in Q1 2014 and has held it in 25 quarters since.
- 748 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2020.
Based on Stellar Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.